Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection—a randomized controlled study

@article{Kato2009ClinicalTR,
  title={Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection—a randomized controlled study},
  author={Tomohiro Kato and Hiroshi Araki and Fumito Onogi and Takashi Ibuka and Akihiko Sugiyama and Eiichi Tomita and Masahito Nagaki and Hisataka Moriwaki},
  journal={Journal of Gastroenterology},
  year={2009},
  volume={45},
  pages={285-290}
}
Endoscopic submucosal dissection (ESD) is useful for treating gastric tumors. Several trials have shown the efficacy of 4 or 8 weeks of proton pump inhibitor (PPI) administration for post-ESD ulcers. However, if the size of the post-ESD ulcer is larger than predicted, PPI administration alone might not be sufficient for the ulcer to heal within 4 weeks. We examined the efficacy of a combination therapy of PPI and rebamipide, a mucosal-protective antiulcer drug, on the acceleration of post-ESD… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

The healing of gastric ulcers after endoscopic submucosal dissection

  • N Kakushima, N Yahagi, M Fujishiro, M Iguchi, M Oka, K Kobayashi
  • Dig Endosc. 2004;16:327–31
  • 2010
3 Excerpts

Similar Papers

Loading similar papers…